Occudo Quantitative Strategies’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMRX
Occudo Quantitative Strategies's AMRX Position: Q3 2026 in Review
Occudo Quantitative Strategies sold out of Amneal Pharmaceuticals (AMRX) in Q3 2026, closing a stake of 97,376 shares — an estimated $1.69M sold.
Occudo Quantitative Strategies first reported a position in AMRX in Q1 2021 and held it in 14 quarters. The position peaked at $1.96M in Q1 2026. 332 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.
- Occudo Quantitative Strategies reported no remaining Amneal Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Occudo Quantitative Strategies sold 97,376 Amneal Pharmaceuticals shares in Q3 2026, an estimated $1.69M.
- Occudo Quantitative Strategies first reported a position in Amneal Pharmaceuticals in Q1 2021 and held it in 14 quarters.
- Occudo Quantitative Strategies's Amneal Pharmaceuticals position peaked at $1.96M in Q1 2026.
- 332 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.
Based on Occudo Quantitative Strategies's 13F filing for Q3 2026, filed 16 Nov 2026.